Sidley represented ReCode Therapeutics in the fundraising. ReCode Therapeutics announced the closing of an extension to its Series B financing. The extension raised an additional $50...
ReCode Therapeutics’ $50 Million Series B Financing Extension
ReCode Therapeutics’ $120 Million Series B Financing
Wilson Sonsini Goodrich & Rosati represented ReCode Therapeutics in the transaction. ReCode Therapeutics, a genetic medicines company using superior delivery to power the next wave of...